Anchorage Capital Group

Anchorage Capital Group is a New York-based investment management firm focused on credit, special situations, and illiquid investments rather than operating as a biotechnology, pharmaceutical, or healthcare company. The firm became known for distressed and opportunistic investing and has invested across a wide range of sectors, including occasional healthcare-related portfolio positions. Its website indicates that Anchorage Capital Advisors, formed in 2022, is the successor organization to Anchorage Capital Group. Because Anchorage is an investor and not a drug developer, it does not have a therapeutic pipeline, clinical programs, or proprietary healthcare platform technology.